InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (40 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
40
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Bergstrom Donald A, Executive. Director active across 2 companies, notably Relay Therapeutics, Inc.. Aggregated, 60 disclosures have been published. Split: 0 buy · 40 sells. Total volume traded: €2.4m. History available since 16 June 2021. The latest transaction was filed on 28 July 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Bergstrom Donald A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations60 total
2,237 shares@ US$18.610.0011% mcap2.1% of flowCommon StockSEC:0001193125-26-326137:0
8,660 shares@ US$18.710.0040% mcap5.8% of flowCommon StockSEC:0001193125-26-298688:0
93,456 sharesCommon StockSEC:0001193125-26-281059:0
93,456 sharesCommon StockSEC:0001193125-26-281059:1
1,490 shares@ US$14.790.0005% mcap0.8% of flowCommon StockSEC:0001193125-26-197395:0
18,895 shares@ US$7.627.3% of flowCommon StockSEC:0001193125-26-029415:0
30,897 shares@ US$7.2912.5% of flowCommon StockSEC:0001193125-25-258557:0
4,069 shares@ US$3.741.0% of flowCommon StockSEC:0000950170-25-100365:0
4,090 shares@ US$3.170.5% of flowCommon StockSEC:0000950170-25-061365:0
27,472 shares@ US$3.003.2% of flowCommon StockSEC:0000950170-25-061365:1
986 shares@ US$2.840.1% of flowCommon StockSEC:0000950170-25-047762:0
3,220 shares@ US$4.630.6% of flowCommon StockSEC:0000950170-25-011319:0
657 shares@ US$4.380.1% of flowCommon StockSEC:0000950170-24-141598:0
2,688 shares@ US$6.060.7% of flowCommon StockSEC:0000950170-24-118981:0
648 shares@ US$7.510.2% of flowCommon StockSEC:0000950170-24-110808:0
2,698 shares@ US$8.851.0% of flowCommon StockSEC:0000950170-24-088812:0
648 shares@ US$6.260.2% of flowCommon StockSEC:0000950170-24-079692:0
2,686 shares@ US$6.380.7% of flowCommon StockSEC:0000950170-24-050146:0
765 shares@ US$7.700.2% of flowCommon StockSEC:0000950170-24-038656:0
3,178 shares@ US$9.641.2% of flowCommon StockSEC:0001209191-24-002470:0
300,000 shares0Common StockSEC:0001209191-24-001837:0
977 shares@ US$11.510.4% of flowCommon StockSEC:0001209191-23-059996:0
3,451 shares@ US$6.030.9% of flowCommon StockSEC:0001209191-23-054020:0
1,228 shares@ US$10.680.7% of flowCommon StockSEC:0001209191-23-050869:0
2,683 shares@ US$11.801.3% of flowCommon StockSEC:0001209191-23-043838:0
25 of 60 declarations
About Bergstrom Donald A
Bergstrom Donald A is an executive and President, R&D at Relay Therapeutics, Inc. (XNAS). He has 59 filings in total, and the 59 sampled filings, over the period from 2021-06-17 to 2026-07-08, show a modal transaction nature of sale, with sum_sell_eur at 2317458 and sum_buy_eur at 0.
